Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 1
2006 2
2007 2
2008 2
2009 4
2011 3
2012 1
2013 5
2014 9
2015 4
2016 4
2017 3
2018 2
2019 5
2020 3
2021 12
2022 8
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
Nishimura T, Fujimoto H, Fujiwara T, Ito K, Fujiwara A, Yuda H, Itani H, Naito M, Kodama S, Furuhashi K, Yagi A, Saiki H, Yasuma T, Okano T, Tomaru A, Tanigawa M, Yoshida M, Hataji O, Ibata H, D'Alessandro-Gabazza CN, Gabazza EC, Kobayashi T. Nishimura T, et al. Cancer Med. 2024 Apr;13(8):e7188. doi: 10.1002/cam4.7188. Cancer Med. 2024. PMID: 38629295 Free PMC article.
Cartilage Conduction Hearing Aids in Clinical Practice.
Nishimura T, Hosoi H, Shimokura R, Kitahara T. Nishimura T, et al. Audiol Res. 2023 Jul 13;13(4):506-515. doi: 10.3390/audiolres13040045. Audiol Res. 2023. PMID: 37489381 Free PMC article. Review.
Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection.
Kogue Y, Kobayashi H, Nakamura Y, Takano T, Furuta C, Kawano O, Yasuma T, Nishimura T, D'Alessandro-Gabazza CN, Fujimoto H, Gabazza EC, Kobayashi T, Fukai I. Kogue Y, et al. Among authors: nishimura t. Pharmaceuticals (Basel). 2023 Feb 7;16(2):255. doi: 10.3390/ph16020255. Pharmaceuticals (Basel). 2023. PMID: 37227446 Free PMC article.
Next-generation sequencing clarified why first-line treatment with osimertinib was ineffective in an autopsied case of EGFR-mutated lung squamous cell carcinoma.
Nishimura T, Fujiwara T, Fujimoto H, Tarumi H, Tsuji C, Iwanaka S, Sakakura Y, Naito M, Okugawa Y, Yasuma T, Gabazza EC, Oomoto Y, Kobayashi T, Ibata H. Nishimura T, et al. Thorac Cancer. 2023 Mar;14(7):709-713. doi: 10.1111/1759-7714.14807. Epub 2023 Jan 29. Thorac Cancer. 2023. PMID: 36710365 Free PMC article.
74 results